1, Shanghai Airport: consumer leading stocks. In 2020, the operating income will be 4.303 billion yuan, a year-on-year increase of-60.68%; The net profit attributable to the parent company was-65.438+0.267 billion yuan, a year-on-year increase of-654.38+0.25.438+0.8%; After deducting non-recurring gains and losses, the net profit attributable to owners of the parent company was-13.82 million yuan, a year-on-year increase of-127.72%.
2. Angel Yeast: the leading consumer stock. In 2020, the operating income was 8.933 billion yuan, up by 65,438+06.73% year-on-year; The net profit attributable to the parent company was 65.438+37.2 million yuan, a year-on-year increase of 52.14%; After deducting non-recurring gains and losses, the net profit attributable to owners of the parent company was 65.438+0.22 billion yuan, a year-on-year increase of 454.38+0%.
3. Hengshun vinegar industry: the leading consumer. Therefore, on the basis of China vinegar industry taking the lead in realizing industrialized production, capitalized operation and brand development, "Hengshun people" are going all out to enter the big health industry and strive to meet consumers' requirements for delicacy, nutrition and health. In 2020, the operating income will be 210.40 billion yuan, up 9.94% year-on-year; The net profit attributable to the parent company was RMB 3,654,380+0.5 million, a year-on-year increase of-3,065,438+0%; After deducting non-recurring gains and losses, the net profit attributable to owners of the parent company is 285 million yuan.
4. Hualan Bio (002007): At present, the consumption of blood products in developed countries in Europe and America accounts for about 80% of the total consumption of blood products in the world, and it is the largest consumption market, with a high per capita consumption of blood products.
5. Jiaying Pharmaceutical (002 198): The company is a Chinese patent medicine manufacturer integrating R&D, production and sales, with more than 70 kinds of drugs in 5 dosage forms, mainly involving throat, cold, orthopedics, rheumatism and other fields. The leading varieties are mostly exclusive products, national traditional Chinese medicine protected varieties, national patent protected varieties and national essential drugs list varieties. Products are favored by consumers, have a certain share and influence in the national market, and have begun to take shape in brand scale.
6. Pathfinder (300005): Outdoor products sector is the cornerstone business of the Group at this stage, focusing on R&D, design, operation management and sales of multi-brand outdoor products. Brand Pathfinder focuses on professional outdoor fields such as mountaineering and hiking, and DiscoveryExpedition brand focuses on outdoor leisure and fashion. Through the development of multi-brand business, we provide consumers with outdoor products with reliable performance and fashionable appearance, which cover the main outdoor life in China at present.
7.CYTS (600 138): The registered capital of China Everbright Consumer Finance Co., Ltd. is 654.38 billion yuan, of which China Everbright Bank contributed 600 million yuan, accounting for 60%; The company invested 200 million yuan, accounting for 20%; Another sponsor contributed 200 million yuan, accounting for 20%.
8. Aucma (600336): The company's main business is the production and sales of refrigeration products (freezers, refrigerators, display cabinets, ice makers and wine cabinets) and household appliances. The big consumption policy is expected to stimulate company sales.
9. Kweichow Moutai (6005 19): the real leader in liquor consumption industry, one of the three largest distilled spirits in the world, representing Tian Fei Maotai. A-share is the highest-priced stock in the A-share market and the largest reservoir. Despite the post-holiday high valuation adjustment, its scarcity and stable performance are still hot core assets, and CITIC upgraded its rating to 3,000 yuan/share.